Viewing Study NCT07155668


Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2026-01-04 @ 4:44 AM
Study NCT ID: NCT07155668
Status: RECRUITING
Last Update Posted: 2025-12-09
First Post: 2025-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
Sponsor: Viridian Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module